Copyright © 2004 American Chemical Society
May 10, 2004 Cover
Volume 82, Issue 19
Volume 82, Issue 19
Protein Drugs
'Big pharma' is weaving biotech into its research regime, developing multiple therapeutic indications for protein drugs
Credit: COVER: Photodisc
» Full Article
May 10, 2004 Issue
Volume 82, Issue 19
May 10, 2004 Issue, Vol. 82 | Iss. 19
'Big pharma' is weaving biotech into its research regime, developing multiple therapeutic indications for protein drugs
(pp. 19-25)
Features
Government & Policy
Presidential directive, ‘hot’ labs to prepare U.S. for bioterrorism
Science & Technology
Chemists gather to paint a 21st-century picture of the resurgent field of main-group chemistry (pp. 39-42)
Cover Story: BIOPHARMACEUTICALS
A NEW BATTLEFIELD IN BIOLOGICS
Having achieved capacity balance, contract service firms move into life-cycle management
(pp. 26-27)News of the Week
NEW STRATEGY, NEW LABS
Presidential directive, ‘hot’ labs to prepare U.S. for bioterrorism
(p.9)PLASTIC FALLOUT IN THE OCEANS
Microscopic polymer bits are accumulating in marine environments
(p.10)SAUDI SHOOTING SPURS ANXIETY
Petrochemical firms may rethink projects after attack on Yanbu facility
(p.10)ACC TO LAUNCH OUTREACH WEBSITE
$20 million authorized in 2005 for public outreach program
(p.12)ACS INSTITUTE GETS NEW DIRECTOR
Paul Anastas will take the helm of Green Chemistry institute in June
(p.13)LEADING SCIENCE INDICATORS
NSB report shows U.S. leadership in science and technology faces hurdles
(p.13)Departments
Business
Having achieved capacity balance, contract service firms move into life-cycle management
(pp. 26-27)
'Big pharma' is weaving biotech into its research regime, developing multiple therapeutic indications for protein drugs
(pp. 19-25)
Cedarburg founders turn to venture-capital funding and find they like it
(p.16)
Corning's chief technology officer chose new challenges over retirement to academia
(p.16)Concentrates
(pp. 14-15)
(pp. 14-15)- BUSINESS CONCENTRATES
- Rohm and Haas to construct major R&D technical center in China
- Dow closing New Jersey plant
- Diamondoids at ChevronTexaco
- Bayer plans isocyanates for China
- Solutia gets new leaders
- Lenzing buys Lyocell unit
- Genencor hikes Japan presence
- Albany scales back research
- Glassell shows up at Cerus
- Chemical demand jumps in March
- Petrobras to control Triunfo
- MG selling more chemical assets
- DOD drops Arch for hydrazine
- BUSINESS ROUNDUP
- All Concentrates
Government & Policy
U.S., EU share views on regulation at trans-Atlantic conference on chemicals
(pp. 29-31)
Lapses in disclosures and delays in chemical arms destruction prompt proliferation fears
(pp. 33-35)
Build more usable nuclear weapons or work to eliminate them all: A debate that needs to be joined
(p.36)
Science & Technology
Chemists gather to paint a 21st-century picture of the resurgent field of main-group chemistry
(pp. 39-42)
Frailty, erectile dysfunction, scarring, and thrombosis/atherosclerosis drugs introduced
(pp. 43-45)
New computational methods for drug design improve modeling of receptor-ligand interactions
(pp. 46-47)
NEW AND NOTABLE IN THE CHEMICAL INDUSTRY
(p.48)